CREO — Creo Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £40.18m
- £44.58m
- £30.80m
- 20
- 38
- 11
- 10
Annual cashflow statement for Creo Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.9 | -20.3 | -24.6 | -26.9 | -21.7 |
| Depreciation | |||||
| Non-Cash Items | -1.41 | -2.3 | -2.65 | -2.4 | -1.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.83 | 4.74 | -1.33 | 1.3 | -1.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.9 | -16.3 | -26 | -24.9 | -21.6 |
| Capital Expenditures | -1.12 | -0.576 | -6.12 | -3.3 | -1.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.311 | -20.4 | -1.72 | -2.7 | -16.7 |
| Acquisition of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.807 | -21 | -7.84 | -6 | -18.3 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.1 | 1.33 | 32 | 0.4 | 29.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36.5 | -36 | -1.56 | -30.4 | -10.1 |